EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Functional inversion of circadian regulator REV-ERBα leads to tumorigenic gene reprogramming

Yatian Yang, Xiong Zhang, Demin Cai, Xingling Zheng, Xuan Zhao, June X Zou iD, Jin Zhang iD, Alexander D Borowsky iD, Marc A Dall'Era, Eva Corey iD, Nicholas Mitsiades iD, Hsing-Jien Kung iD und 5 weitere

Proceedings of the National Academy of Sciences · 2024

DOI: 10.1073/pnas.2411321121 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Proceedings of the National Academy of Sciences, 2024. Verfasst von Yatian Yang und 16 weiteren Autor:innen. Beteiligte Einrichtung: Department of Biochemistry and Molecular Medicine, School of Medicine, University of California Davis, Sacramento, CA 95817. Hauptthemen laut MEDLINE: Nuclear Receptor Subfamily 1, Group D, Member 1, Circadian Rhythm, Carcinogenesis. Die Arbeit wurde bisher 16-mal zitiert (Crossref) und nennt 55 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: NCI NIH HHS, BLRD VA.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Profound functional switch of key regulatory factors may play a major role in homeostasis and disease. Dysregulation of circadian rhythm (CR) is strongly implicated in cancer with mechanisms poorly understood. We report here that the function of REV-ERBα, a major CR regulator of the orphan nuclear receptor subfamily, is dramatically altered in tumors in both its genome binding and functional mode. Loss of CR is linked to a functional inversion of REV-ERBα from a repressor in control of CR and metabolic gene programs in normal tissues to a strong activator in different cancers. Through changing its association from NCoR/HDAC3 corepressor complex to BRD4/p300 coactivators, REV-ERBα directly activates thousands of genes including tumorigenic programs such as MAPK and PI3K-Akt signaling. Functioning as a master transcriptional activator, REV-ERBα partners with pioneer factor FOXA1 and directly stimulates a large number of signaling genes, including multiple growth factors, receptor tyrosine kinases, RASs, AKTs, and MAPKs. Moreover, elevated REV-ERBα reprograms FOXA1 to bind new targets through a BRD4-mediated increase in local chromatin accessibility. Pharmacological targeting with SR8278 diminishes the function of both REV-ERBα and FOXA1 and synergizes with BRD4 inhibitor in effective suppression of tumorigenic programs and tumor growth. Thus, our study revealed a functional inversion by a CR regulator in driving gene reprogramming as an unexpected paradigm of tumorigenesis mechanism and demonstrated a high effectiveness of therapeutic targeting such switch.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Nuclear Receptor Subfamily 1, Group D, Member 1Circadian RhythmCarcinogenesisHumansAnimalsMiceGene Expression Regulation, NeoplasticTranscription FactorsHepatocyte Nuclear Factor 3-alphaSignal TransductionCell Line, TumorNeoplasmsCell Cycle ProteinsNuclear Receptor Co-Repressor 1Bromodomain Containing Proteins

Stichwörter der Autor:innen

CRPCREV-ERBαantagonistliverprostate

Substanzen

Nuclear Receptor Subfamily 1, Group D, Member 1Transcription FactorsHepatocyte Nuclear Factor 3-alphaBRD4 protein, humanNR1D1 protein, humanFOXA1 protein, humanCell Cycle ProteinsNuclear Receptor Co-Repressor 1Bromodomain Containing Proteins

Autor:innen und Institutionen

  • Department of Biochemistry and Molecular Medicine, School of Medicine, University of California Davis, Sacramento, CA 95817.
  • Gene Expression Laboratory, Salk Institute for Biological Studies, La Jolla, CA 92037.
  • Department of Surgical & Radiological Sciences, University of California-Davis, Davis, CA 95616.
  • Department of Pathology and Laboratory Medicine, School of Medicine, University of California Davis, Sacramento, CA 95817.
  • Department of Urologic Surgery, School of Medicine, University of California Davis, Sacramento, CA 95817.
  • Department of Urology, University of Washington, Seattle, WA 98195.

ORCID-Profile: June X Zou, Jin Zhang, Alexander D Borowsky, Eva Corey, Nicholas Mitsiades, Hsing-Jien Kung, Jian Jian Li, Michael Downes, Ronald M Evans

Förderung

  • NCI NIH HHS
  • BLRD VA

Zitieren

APA

Yang, Y., Zhang, X., Cai, D., Zheng, X., Zhao, X., Zou, J. X., Zhang, J., Borowsky, A. D., Dall'Era, M. A., Corey, E., Mitsiades, N., Kung, H. J., Chen, X., Li, J. J., Downes, M., Evans, R. M., & Chen, H. W. (2024). Functional inversion of circadian regulator REV-ERBα leads to tumorigenic gene reprogramming. Proceedings of the National Academy of Sciences. https://doi.org/10.1073/pnas.2411321121

Vancouver

Yang Y, Zhang X, Cai D, Zheng X, Zhao X, Zou JX, et al. Functional inversion of circadian regulator REV-ERBα leads to tumorigenic gene reprogramming. Proceedings of the National Academy of Sciences. 2024. doi:10.1073/pnas.2411321121

BibTeX
@article{Yang2024,
  author = {Yang, Yatian and Zhang, Xiong and Cai, Demin and Zheng, Xingling and Zhao, Xuan and Zou, June X and Zhang, Jin and Borowsky, Alexander D and Dall'Era, Marc A and Corey, Eva and Mitsiades, Nicholas and Kung, Hsing-Jien and Chen, Xinbin and Li, Jian Jian and Downes, Michael and Evans, Ronald M and Chen, Hong-Wu},
  title = {Functional inversion of circadian regulator REV-ERBα leads to tumorigenic gene reprogramming},
  journal = {Proceedings of the National Academy of Sciences},
  year = {2024},
  doi = {10.1073/pnas.2411321121}
}
Kostenlos starten →